2023
DOI: 10.1002/cmdc.202200580
|View full text |Cite
|
Sign up to set email alerts
|

4‐O‐Substituted Glucuronic Cyclophellitols are Selective Mechanism‐Based Heparanase Inhibitors

Abstract: Supporting information for this article is given via a link at the end of the document.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 34 publications
(62 reference statements)
0
4
0
Order By: Relevance
“…We next examined whether the synthetic 1- N -iminosugars could inhibit HPSE and human β-glucuronidase. To assess the potency of these inhibitors, we used a competitive activity-based protein profiling (cABPP) assay, that measures the ability of the inhibitor to reduce fluorescent labeling of an enzyme by a fluorescent pan-β-glucuronidase activity-based probe (ABP). , Using this cABPP assay, we can simultaneously monitor the inhibition of HPSE and GUSB that are both present in platelet lysates. , As for the bacterial β-glucuronidases, human GUSB was also effectively inhibited by all the synthesized inhibitors ( 8 – 11 ), with low or submicromolar IC 50 ’s observed, see Table and Figures , S7–S9. As observed with the bacterial β-glucuronidases, the gluco -configured inhibitors 9 and 11 were more potent inhibitors of human GUSB than their 4-axial galacto -analogues.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…We next examined whether the synthetic 1- N -iminosugars could inhibit HPSE and human β-glucuronidase. To assess the potency of these inhibitors, we used a competitive activity-based protein profiling (cABPP) assay, that measures the ability of the inhibitor to reduce fluorescent labeling of an enzyme by a fluorescent pan-β-glucuronidase activity-based probe (ABP). , Using this cABPP assay, we can simultaneously monitor the inhibition of HPSE and GUSB that are both present in platelet lysates. , As for the bacterial β-glucuronidases, human GUSB was also effectively inhibited by all the synthesized inhibitors ( 8 – 11 ), with low or submicromolar IC 50 ’s observed, see Table and Figures , S7–S9. As observed with the bacterial β-glucuronidases, the gluco -configured inhibitors 9 and 11 were more potent inhibitors of human GUSB than their 4-axial galacto -analogues.…”
Section: Resultsmentioning
confidence: 99%
“…To assess the potency of these inhibitors, we used a competitive activitybased protein profiling (cABPP) assay, that measures the ability of the inhibitor to reduce fluorescent labeling of an enzyme by a fluorescent pan-β-glucuronidase activity-based probe (ABP). 16,34 Using this cABPP assay, we can simultaneously monitor the inhibition of HPSE and GUSB that are both present in platelet lysates. 6,29 As for the bacterial βglucuronidases, human GUSB was also effectively inhibited by all the synthesized inhibitors (8−11), with low or submicromolar IC 50 's observed, see Table 3…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 2 more Smart Citations